Capreomycin in the treatment of atypical mycobacterial disease in HIV-positive patients.
Göbels
K
K
Klinik für Gastroenterologie, Hepatologie und Infektiologie, Universitätsklinikum Düsseldorf, Moorenstrasse 5, 40225 Düsseldorf, Germany. goebels@med.uni-duesseldorf.de
Hemker
J
J
Oette
M
M
Wettstein
M
M
Heintges
T
T
Teichmann
D
D
MacKenzie
C R
CR
Häussinger
D
D
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002207:Capreomycin / Q000627:therapeutic use*; D005260:Female; D006679:HIV Seropositivity / Q000150:complications / Q000382:microbiology; D006801:Humans; D008297:Male; D009161:Mycobacterium / Q000302:isolation & purification; D009165:Mycobacterium Infections, Nontuberculous / Q000150:complications* / Q000188:drug therapy*
D000995:Antitubercular Agents; D002207:Capreomycin